Andrew Ellingsen represents clients in a variety of industries in antitrust and competition matters, including government review of mergers and acquisitions, filing obligations under the Hart-Scott-Rodino Act, complex civil litigation, and counseling clients in relation to antitrust issues.
Andrew received his J.D. from the University of Virginia School of Law, where he served at the Senior Review Editor of the Virginia Law & Business Review. Prior to law school, Andrew worked as an honors paralegal at the Federal Trade Commission, working on investigations and litigations involving mergers and anticompetitive practices. He received his Bachelors of Science from Duke University in Economics.
Experience
- Pfizer in its $43 billion acquisition of Seagen Inc., a world-leader in antibody-drug conjugates (ADCs).
Perspectives
April 18, 2024
Antitrust Agency Insights: Developments at the U.S. Antitrust Enforcement Agencies — First Quarter 2024
Newsletter
December 7, 2021
DOJ Defeats Motion to Dismiss in Precedent-Setting Criminal Wage-Fixing Case
Advisory
Credentials
Education
- J.D., University of Virginia School of Law, 2020
- B.S., Economics, Duke University, 2013
Admissions
- District of Columbia